Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
O'Brien Stephanie Monaghan reported 1 trade in Apellis Pharmaceuticals, Inc. shares (Form 4)
Traded Apr 6, 2026 · Filed Apr 8, 2026
On Apr 6, 2026, O'Brien Stephanie Monaghan (Director) reported 1 trade in Apellis Pharmaceuticals, Inc. shares, leaving 5,750 shares. Filed Apr 8, 2026 (Form 4).
- Shares
- 5,750 shares
- Holding after
- 5,750 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 6, 2026 | Common Stock | Other | 5,750 | 5,750 | Indirect |
Source
Related
- Apellis Pharmaceuticals, Inc.
- O'Brien Stephanie Monaghan
- Apellis Pharmaceuticals, Inc. shareholders
- Form 4 · O'Brien Stephanie Monaghan · May 14, 2026
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026